Suchergebnisse
Katalog
Aufsätze & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- pharmaceutical industry 49 Treffer
- alexion pharmaceuticals inc. 47 Treffer
- alexza pharmaceuticals inc. 26 Treffer
- swot analysis 18 Treffer
- clinical trials 16 Treffer
-
45 weitere Werte:
- drug development 14 Treffer
- alexander's inc. 11 Treffer
- real estate investment trusts 11 Treffer
- bipolar disorder 10 Treffer
- schizophrenia treatment 10 Treffer
- agitation (psychology) 8 Treffer
- drug efficacy 8 Treffer
- therapeutics 8 Treffer
- biovail laboratories international srl 4 Treffer
- business cycles 4 Treffer
- business finance 4 Treffer
- clinical drug trials 4 Treffer
- corporate growth 4 Treffer
- corporate profits 4 Treffer
- corporations 4 Treffer
- financial performance 4 Treffer
- industrial location 4 Treffer
- medical research 4 Treffer
- novartis ag 4 Treffer
- people with schizophrenia 4 Treffer
- schizophrenia 4 Treffer
- united states. food & drug administration 4 Treffer
- revenue 3 Treffer
- albany molecular research inc. 2 Treffer
- allergens 2 Treffer
- antiasthmatic agents 2 Treffer
- bayer healthcare pharmaceuticals inc. 2 Treffer
- biotechnology industries 2 Treffer
- bristol-myers squibb co. 2 Treffer
- business partnerships 2 Treffer
- business success 2 Treffer
- central nervous system diseases 2 Treffer
- cephalon inc. 2 Treffer
- clinical medicine research 2 Treffer
- cypress bioscience inc. 2 Treffer
- drug approval 2 Treffer
- drug patents 2 Treffer
- drugs 2 Treffer
- economic competition 2 Treffer
- endo pharmaceuticals inc. 2 Treffer
- european commission 2 Treffer
- immune response 2 Treffer
- immunoglobulins 2 Treffer
- industries 2 Treffer
- johnson & johnson innovative medicine (company) 2 Treffer
Publikation
Sprache
Geographischer Bezug
Inhaltsanbieter
88 Treffer
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2023-09-28, S. 1-6Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2022-11-28, S. 1-6Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2021-11-01, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2020-11-05, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2019-11-24, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2018-06-11, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2017-08-18, S. 1-7Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2016-05-19, S. 1-8Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2015, S. 1-8Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc.: Focus on Ultra-Rare Diseases as a Revenue & Profit Driver, 2013, S. 1-23Online reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-12-01), Heft 12, S. 13-16Online reportZugriff:
-
In: PharmaWatch: Biotechnology, Jg. 8 (2009-05-01), Heft 5, S. 10-13Online reportZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2004, S. 5-9Online unknownZugriff:
-
In: Alexion Pharmaceuticals, Inc. SWOT Analysis, 2004, S. 1-9Online unknownZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-10-01), Heft 10, S. 13-14Online reportZugriff:
-
In: PharmaWatch: Monthly Review, Jg. 9 (2010-07-01), Heft 7, S. 12-13Online reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-03-01), Heft 3, S. 9-10Online reportZugriff:
-
In: PharmaWatch: CNS, Jg. 9 (2010-02-01), Heft 2, S. 10-11Online reportZugriff:
-
In: PharmaWatch: CNS, Jg. 7 (2008-10-01), Heft 10, S. 10-11Online reportZugriff:
-
In: PharmaWatch: CNS, Jg. 7 (2008-07-01), Heft 7, S. 12-13Online reportZugriff: